Human Placental Extract and its Formulations is back in India vide the Gazette Notification No. G.S.R 418(E) dated May 30, 2011 - the Ministry of Health & Family Welfare...... USE OF PLACENTREX CONTINUES!
Related Posts Plugin for WordPress, Blogger...

Friday, March 11, 2011

Inj. placentrex in treatment of PID (pelvic inflammatory disease)

This post highlights the efficacy of Placentrex Injection (Human Placental Extract), the brand product of Albert David Ltd., Kolkata, India who are pioneer in India in manufacturing human placental extract products. According to Dr. Nutan Agarwal of AIIMS, New Delhi, India the combination of Placentrex Injection with antimicrobial therapy can be a better option for treating PID than only antimicrobial therapy. In this context the reader should know that the Indian Institute of Chemical Biology (IICB), Calcutta plays vital role in the research work on Human Placental Extract.

Now here is one such study which highlights the efficacy of human placental extract in treatment of PID in females:

J Indian Med Assoc. 2008 Jul;106(7):463, 467.
Garg R, Zahra F, Chandra JA, Vatsal P.
Department of Obstetrics and Gynaecology, Era's Lucknow Medical College, Lucknow 226003.

TOPIC: A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease.

To compare the effect of placentrex injection given along with conventional therapy, with conventional treatment alone on the symptoms and signs of pelvic inflammatory disease (PID) ie, abdominal pain, dysmenorrhoea and adnexal tenderness, 50 out of 100 women with PID were randomly assigned to receive intramuscular placentrex injection along with two-week conventional therapy and 50 received conventional treatment only. Abdominal pain, dysmenorrhoea and adnexal tenderness were evaluated at the end of 2 months. There was marked reduction in the sign of adnexal tenderness in the placentrex group as compared to conventional treatment group (p < 0.001). Subjective symptoms of lower abdominal pain and dysmenorrhoea were also relieved better in placentrex group (p < 0.01 and 0.05 respectively). This study showed significant and persistent improvement of signs and symptoms of PID in women who received injection placentrex.
PMID: 18975504 [PubMed - indexed for MEDLINE]
Courtesy: PubMed

No comments:

Post a Comment